Bankruptcy: Endo, Inc.

Form Type: 10-K

Filing Date: 2025-03-13

Corporate Action: Bankruptcy

Type: Update

Accession Number: 000200886125000007

Filing Summary: Endo, Inc. has filed its 10-K for the fiscal year ended December 31, 2024. The document details the company's plans for reorganization under Chapter 11, which includes provisions related to asset impairments, restructuring initiatives, and ongoing risks related to customer concentration. The report outlines significant financial metrics, including revenues, costs associated with operating segments like Generic Pharmaceuticals and Branded Pharmaceuticals, and the impact of restructuring on financial projections. Additionally, the filing provides insights into management discussions regarding debt adjustments and operational strategies moving forward.

Document Link: View Document